Article
REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer
1 Mar 2007
Abstract excerpt
Human testicular cancer is very sensitive to chemotherapy and radiation therapy and is regarded as a curable cancer. The cancer prevails in the young reproductive generation and testicular dysfunction is often observed as a side effect, remaining a serious challenge. In the present study, we examined the potential utility of REIC/Dkk-3-based gene therapy against human testicular cancer. Expression of REIC/Dkk-3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
